在线定制决策辅助工具促进荷兰孕产妇百日咳疫苗接种知情决策的效果:一项随机对照试验
在荷兰开展随机对照试验,将1236名孕妇随机分为对照组(650人,无信息)和干预组(586人,孕18周使用在线决策辅助工具),评估其对知情决策和孕产妇百日咳疫苗接种率的影响。干预未显著影响接种率(样本接种率92.3%),但提高了知情决策(β=0.24,p<.004)及知识、决策确定性等次要结局。
要点
- 在线决策辅助工具未显著提高孕产妇百日咳疫苗接种率。
- 干预提高了知情决策(β=0.24)及疫苗知识(β=0.31)。
- 接种率与决策辅助工具使用剂量呈正相关(β=0.05)。
核心结论
- 决策辅助工具似乎能有效促进关于孕产妇百日咳疫苗接种的知情决策及其决定因素;未发现对接种率的主效应,但接种率与干预暴露水平相关。
研究设计与样本
- 随机对照试验,纳入1236名孕妇,随机分为对照组(650人,无信息)和干预组(586人,孕18周使用在线决策辅助工具),在意向性治疗人群中分析。
主要发现
- 样本中孕产妇百日咳疫苗接种率高达92.3%。
- 与对照组相比,决策辅助工具对接种率无显著影响。
- 干预组知情决策高于对照组(β=0.24,p<.004)。
- 干预组疫苗知识水平高于对照组(β=0.31,p<.004)。
- 干预组决策确定性(β=0.24)、感知易感性(β=0.24)、百日咳严重性(β=0.41)和积极情感(β=0.15)均高于对照组(均p<.004)。
关键数值与推荐
- 知情决策的组间差异:β=0.24,p<.004。
- 疫苗知识的组间差异:β=0.31,p<.004。
- 决策确定性的组间差异:β=0.24,p<.004。
- 感知易感性的组间差异:β=0.24,p<.004。
- 百日咳严重性的组间差异:β=0.41,p<.004。
临床怎么用
- 决策辅助工具似乎可有效促进关于孕产妇百日咳疫苗接种的知情决策及其决定因素。
- 未发现决策辅助工具对接种率的主效应。
- 接种率与决策辅助工具的暴露水平相关。
局限性
- 样本中对孕产妇百日咳疫苗接种意向高者占比过高。
- 对知情决策的效果在不同基线接种意向水平的参与者中一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In 2019, maternal pertussis vaccination (MPV) during pregnancy was introduced in the Netherlands. New interventions to promote informed decision making (IDM) about vaccinations are highly needed, especially for new vaccinations. Decision aids (DAs) have the potential to support IDM. This study evaluates the effects of an online DA on IDM and MPV uptake. METHODS: Pregnant individuals, recruited for the randomized controlled trial (RCT), who gave informed consent (N = 1,236) were randomly assigned to the control (N = 650; no information) or intervention condition (N = 586; DA at 18 weeks pregnancy). MPV uptake and IDM were primary outcomes, decisional certainty and psychological determinants of MPV uptake were secondary outcomes. Measures were taken at 18 weeks of pregnancy (baseline) and at 20 weeks of pregnancy (post-test); intervention use was logged. Data were analysed using intention-to-treat analyses, logistic regression, and linear mixed regression models. RESULTS: Uptake of MPV was high in our sample (92.3 %). No significant effect of the DA condition on MPV uptake was found compared to the control condition. We found that the DA increased IDM (β = 0.24, p < .004) and one of its components level of knowledge about MPV (β = 0.31, p < .004). We also found an increase in decisional certainty (β = 0.24, p < .004), perceived susceptibility (β = 0.24, p < .004), severity of pertussis (β = 0.41, p < .004), and positive affect about MPV (β = 0.15, p < .004). There was a positive association between dose of the intervention and MPV uptake (β = 0.05, p < .004). DISCUSSION: The DA seemed effective in promoting IDM about and determinants of MPV uptake. No main effect was found on MPV uptake, but MPV uptake was related to the level of exposure to the DA. People with high intentions towards MPV were overrepresented in the sample. However, effects on IDM were consistent among participants with different levels of MPV intention at baseline.
引用
- Anraad C, van Empelen P, Ruiter RAC, et al. Effects of an online tailored decision aid to promote informed decision making about maternal pertussis vaccination in the Netherlands: A randomized controlled trial. Vaccine. 2023. PMID: 37977943. doi:10.1016/j.vaccine.2023.10.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。